1. Home
  2. SCLX vs MYPS Comparison

SCLX vs MYPS Comparison

Compare SCLX & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.48

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.47

Market Cap

55.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
MYPS
Founded
2011
2011
Country
United States
United States
Employees
34
543
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
55.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
MYPS
Price
$6.48
$0.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
92.4K
505.1K
Earning Date
04-10-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.09
$0.40
52 Week High
$34.27
$1.60

Technical Indicators

Market Signals
Indicator
SCLX
MYPS
Relative Strength Index (RSI) 39.05 52.65
Support Level $6.20 $0.42
Resistance Level $8.18 $0.51
Average True Range (ATR) 1.38 0.05
MACD -0.32 0.01
Stochastic Oscillator 1.16 44.75

Price Performance

Historical Comparison
SCLX
MYPS

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Companies games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

Share on Social Networks: